Lineage Cell Therapeutics (LCTX) Goodwill & Intangibles (2016 - 2025)
Historic Goodwill & Intangibles for Lineage Cell Therapeutics (LCTX) over the last 16 years, with Q3 2025 value amounting to $42.4 million.
- Lineage Cell Therapeutics' Goodwill & Intangibles fell 4483.89% to $42.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.4 million, marking a year-over-year decrease of 4483.89%. This contributed to the annual value of $57.2 million for FY2024, which is 3.84% down from last year.
- According to the latest figures from Q3 2025, Lineage Cell Therapeutics' Goodwill & Intangibles is $42.4 million, which was down 4483.89% from $42.4 million recorded in Q2 2025.
- Lineage Cell Therapeutics' 5-year Goodwill & Intangibles high stood at $76.8 million for Q1 2021, and its period low was $42.4 million during Q2 2025.
- Its 5-year average for Goodwill & Intangibles is $62.9 million, with a median of $57.2 million in 2024.
- In the last 5 years, Lineage Cell Therapeutics' Goodwill & Intangibles surged by 3435.77% in 2023 and then plummeted by 4483.89% in 2025.
- Over the past 5 years, Lineage Cell Therapeutics' Goodwill & Intangibles (Quarter) stood at $76.8 million in 2021, then changed by 0.0% to $76.8 million in 2022, then fell by 25.49% to $57.2 million in 2023, then fell by 0.04% to $57.2 million in 2024, then decreased by 25.94% to $42.4 million in 2025.
- Its Goodwill & Intangibles stands at $42.4 million for Q3 2025, versus $42.4 million for Q2 2025 and $57.2 million for Q1 2025.